Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

Who needs Ozempic to stop feeling hungry? Yes, the active ingredient semaglutide in the weight loss wonder drug helps to keep ...

The FDA has updated the labels for all GLP-1 receptor agonists, including popular medications Ozempic, Wegovy, Saxenda and Mounjaro, to include a new warning about the risk of pulmonary aspiration ...

This is just a glimpse of the GLP-1 insights available to CivicScience clients. Want to see the full picture? Let’s talk.

There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new recommendations.

Stroke was the fourth leading cause of death in the US last year, accounting for 162,600 deaths, according to preliminary data.

However, interest in GLP-1 drugs, particularly Ozempic, has also been fueled in part by social media discourse and ...

Novo Nordisk is known for its blockbuster GLP-1 drugs Wegovy and Ozempic. These drugs mimic a hormone that regulates appetite and blood sugar and have become highly sought after as treatments for ...